Incannex Healthcare Inc. (NASDAQ: IXHL) Stock Information | RedChip

Incannex Healthcare Inc. (NASDAQ: IXHL) Listen to this Section


$1.57
-0.2200 ( -12.30% ) 205.9K

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Market Data


Open


$1.57

Previous close


$1.79

Volume


205.9K

Market cap


$27.17M

Day range


$1.51 - $2.00

52 week range


$0.80 - $12.68

Insider Ownership Transactions

Total Amount Purchased: -2,310,000.00 | $ -3,626,700.00

Date Type Amount Purchased Purchaser
2023-12-21 Sale -100000.00 Clark Robert
2023-12-21 Sale -100000.00 Anastassov George
2023-12-21 Sale -1340000.00 Latham Joel
2023-12-21 Sale -100000.00 Widdows Peter
2023-12-21 Sale -670000.00 Valentine Troy

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 05, 2024
5 Other 1 Aug 02, 2024
8-k 8K-related 15 Jul 30, 2024
8-k 8K-related 15 May 30, 2024
10-q Quarterly Reports 78 May 15, 2024
8-k 8K-related 15 May 07, 2024
8-k 8K-related 15 Apr 16, 2024
8-k 8K-related 16 Mar 05, 2024
8-k 8K-related 17 Feb 28, 2024
8-k 8K-related 16 Feb 16, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.